Literature DB >> 26449704

Patient support interventions to improve adherence to drug-resistant tuberculosis treatment: A counselling toolkit.

E Mohr1, J Hughes, L Snyman, B Beko, X Harmans, J Caldwell, H Duvivier, L Wilkinson, V Cox.   

Abstract

In response to the growing burden of drug-resistant tuberculosis (DR-TB) in South Africa (SA), Médecins Sans Frontières (MSF), with local government health departments, piloted a decentralised model of DR-TB care in Khayelitsha, Western Cape Province, in 2007. The model takes a patient-centred approach to DR-TB treatment that is integrated into existing TB and HIV primary care programmes. One essential component of the model is individual and family counselling to support adherence to and completion of treatment. The structured and standardised adherence support sessions have been compiled into a DR-TB counselling toolkit. This is a comprehensive guide that focuses on DR-TB treatment literacy, adherence strategies to encourage retention in care, and provision of support throughout the patient's long treatment journey. Along with other strategies to promote completion of treatment, implementation of a strong patient support component of DR-TB treatment is considered essential to reduce rates of loss from treatment among DR-TB patients. We describe our experience from the implementation of this counselling model in a high DR-TB burden setting in Khayelitsha, Cape Town, SA.

Entities:  

Year:  2015        PMID: 26449704     DOI: 10.7196/samj.10093

Source DB:  PubMed          Journal:  S Afr Med J


  6 in total

1.  A pilot model of patient education and counselling for drug-resistant tuberculosis in Daru, Papua New Guinea.

Authors:  T Adepoyibi; T Keam; A Kuma; T Haihuie; M Hapolo; S Islam; B Akumu; K Chani; L Morris; M Taune
Journal:  Public Health Action       Date:  2019-09-21

2.  Training social workers to enhance patient-centered care for drug-resistant TB-HIV in South Africa.

Authors:  J R Zelnick; B Seepamore; A Daftary; K R Amico; X Bhengu; G Friedland; N Padayatchi; K Naidoo; M R O'Donnell
Journal:  Public Health Action       Date:  2018-03-21

3.  Acceptability, feasibility, and impact of a pilot tuberculosis literacy and treatment counselling intervention: a mixed methods study.

Authors:  Stephanie Law; Boitumelo Seepamore; Olivia Oxlade; Nondumiso Sikhakhane; Halima Dawood; Sheldon Chetty; Nesri Padayatchi; Dick Menzies; Amrita Daftary
Journal:  BMC Infect Dis       Date:  2021-05-18       Impact factor: 3.090

4.  Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study.

Authors:  Mandla Mlotshwa; Natasha Abraham; Moira Beery; Seymour Williams; Sandra Smit; Margot Uys; Carl Reddy; Andrew Medina-Marino
Journal:  BMC Infect Dis       Date:  2016-08-02       Impact factor: 3.090

5.  DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting.

Authors:  Erika Mohr; Johnny Daniels; Busisiwe Beko; Petros Isaakidis; Vivian Cox; Sarah Jane Steele; Odelia Muller; Leigh Snyman; Virginia De Azevedo; Amir Shroufi; Laura Trivino Duran; Jennifer Hughes
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

6.  "Life continues": Patient, health care and community care workers perspectives on self-administered treatment for rifampicin-resistant tuberculosis in Khayelitsha, South Africa.

Authors:  Erika Mohr; Leigh Snyman; Zodwa Mbakaz; Judy Caldwell; Virginia DeAzevedo; Yulene Kock; Laura Trivino Duran; Emilie Venables
Journal:  PLoS One       Date:  2018-09-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.